🟢 LifeMD is trading 6.71% up in pre-market amid stronger technology and growth-stock sentiment

LifeMD is trading at $3.50 (+6.71%), broadly aligned with stronger pre-market technology and growth-stock sentiment.

• No new company-specific announcement or filing was identified for August 21, 2026.
• The Nasdaq Composite was up 0.58%.
• Recent earnings remain a potential background factor: second-quarter revenue was $47.3 million, while full-year revenue guidance was reduced to $205.5 million-$212.5 million.